Evidence map›Paper›PMID 38545221›Full record

ArticleHeliyon2024

An

Latif Adams, Dorcas Obiri-Yeboah, Michael Afiadenyo, Sherif Hamidu, Abigail Aning, Ebenezer Ehun, Katie Shiels, Akanksha Joshi, Maxwell Mamfe Sakyimah, Kwadwo Asamoah Kusi and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Veterinary sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Latif AdamsTechnological University of Shannon: Midlands Midwest, Midlands Campus, Athlone, Ireland.
Dorcas Obiri-YeboahDepartment of Microbiology and Immunology, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.
Michael AfiadenyoDepartment of Parasitology, Noguchi Memorial Institute for Medical Research (NMIMR), College of Health Sciences (CHS), University of Ghana, Legon, Accra, Ghana.
Sherif HamiduDepartment of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, P.O. Box LG 581, Legon, Ghana.
Abigail AningDepartment of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, P.O. Box LG 581, Legon, Ghana.
Ebenezer EhunCentre for Plant Medicine Research, Mampong-Akuapem, Ghana.
Katie ShielsShannon Applied Biotechnology Centre(ABC), Technological University of Shannon, Moylish Park, Limerick, Ireland.
Akanksha JoshiShannon Applied Biotechnology Centre(ABC), Technological University of Shannon, Moylish Park, Limerick, Ireland.
Maxwell Mamfe SakyimahCentre for Plant Medicine Research, Mampong-Akuapem, Ghana.
Kwadwo Asamoah KusiDepartment of Immunology, Noguchi Memorial Institute for Medical Research (NMIMR), College of Health Sciences (CHS), University of Ghana, Legon, Accra, Ghana.
Irene AyiDepartment of Parasitology, Noguchi Memorial Institute for Medical Research (NMIMR), College of Health Sciences (CHS), University of Ghana, Legon, Accra, Ghana.
Michelle Mckeon BennettTechnological University of Shannon: Midlands Midwest, Midlands Campus, Athlone, Ireland.
Siobhan MoaneTechnological University of Shannon: Midlands Midwest, Midlands Campus, Athlone, Ireland.
University of Ghana · GHShannon Applied Biotechnology Centre · IETechnological University of the Shannon: Midlands MidwestUniversity of Cape Coast · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

African Trypanosomiasis caused by trypanosome parasites continues to be a major neglected health problem, particularly in developing countries. Current treatments are marked by serious side effects, low effectiveness, high toxicity, and drug resistance prompting the need to develop novel, safe, effective, and alternative antitrypanosomal compounds.

Indexed as

Anopyxis klaineanaAntitrypanosomal activityIn-silicoLC-MS analysisTrypanothione reductaseUridine diphosphate galactose 4′-Epimerase

Identifiers

PMID38545221
PMCPMC10966600
OpenAlexW4392877733

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.